Global semiconductor developer BluGlass Limited (ASX: BLG) has completed the consolidation of the Company’s issued capital of on the basis of 1 share for every 20 shares and 1 option for every 20 options; following shareholder approval at the Company’s Annual General Meeting held on 24 November 2025.
The post-consolidation securities on issue are as follows:
| Security Code | Security Description | Balance |
| BLG | Ordinary Fully Paid | 130,732,042 |
| BLGAB | Options Expiring 31 May 2026 EX $0.26 | 10,017,055 |
| BLGAC | Options Expiring 31 May 2026 EX $0.26 | 27,740,408 |
| BLGAL | Performance Rights | 2,530,853 |
| BLGAQ | Options Expiring 24 Mar 2026 EX $2.4 | 200,000 |
| BLGAR | Options Expiring 31 May 2028 EX $0.38 | 3,590 |
| BLGAA | Options Expiring 28 Feb 2027 EX $1.2 | 16,157 |
New holding statements on a post-consolidation basis will be dispatched to shareholders as at today’s date. The consolidated shares will recommence trading on Friday 5 December.
In accordance with the terms of the resolution approved at the Annual General Meeting, where the Consolidation resulted in a fraction of a security being held, the Company rounded fractions up to the next whole number. We further note that any discrepancy outlined in the table above is due to the 20:1 consolidation being applied and rounded on an individual holder basis rather than to the total figure. Therefore, on the basis that multiple consolidated holdings are rounded up, the final consolidated figure is larger than the rounding applied once to the straight 20:1 calculation.
About BluGlass
BluGlass Limited (ASX:BLG) is a leading supplier of GaN laser diode products to the global photonics industry, focused on the industrial, defence, bio-medical, and scientific markets.
Listed on the ASX, BluGlass is one of just a handful of end-to-end GaN laser manufacturers globally. Its operations in Australia and the US offer cutting-edge, custom laser diode development and manufacturing, from small-batch custom lasers to medium and high-volume off-the-shelf products.
Its proprietary low temperature, low hydrogen, remote plasma chemical vapour deposition (RPCVD) manufacturing technology and novel device architectures are internationally recognised, and provide the potential to create brighter, better performing lasers to power the devices of tomorrow.
